🔎 Trials Near Me

Hjem › Endetarmskreft › New York › New York City

Kliniske studier for Endetarmskreft i New York City, NY

17 studier for Endetarmskreft søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

RekruttererFase 3
  • Memorial Sloan Kettering Cancer Center ( Site 0095), New York
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06997497

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

RekruttererFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07227636

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RekruttererFase 1/2
  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

RekruttererFase 1/2
  • NYU Langone Health Perlmutter Cancer Center, New York
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07629960

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

RekruttererFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT04165772

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Rekrutterer
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Alder 45 til 70 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05080673

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

RekruttererFase 2
  • Weill Cornell Medical College, New York
  • Brooklyn Methodist Hospital - NewYork Presbyterian, New York
  • New York Presbyterian Hospital - Queens, New York
Alder 18 til 90 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT05024097

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

RekruttererFase 3
  • Memorial Sloan Kettering Cancer Center, New York
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT06205485

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

Rekrutterer
  • Weill Cornell Medical College, New York
  • New York Presbyterian Hospital - Queens, New York
Alder 18 til 90 · Alle kjønn · Oppdatert 15. jun. 2026 · NCT05943210

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

RekruttererFase 1/2
  • NYU Langone Medical Center, New York
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT06051695

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

Rekrutterer
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jun. 2026 · NCT06637462

Brodalumab in the Treatment of Immune-Related Adverse Events

RekruttererFase 1
  • Columbia University Irving Medical Center, New York
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT06673329

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

RekruttererFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Alder 18 og eldre · Alle kjønn · Oppdatert 12. mai 2026 · NCT05672524

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

RekruttererObservasjonsstudie
  • Memorial Sloan Kettering Cancer Center, New York
Alder 18 og eldre · Alle kjønn · Oppdatert 12. mar. 2026 · NCT04668872

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

RekruttererFase 2
  • Columbia University Irving Medical Center, New York
Alder 18 og eldre · Alle kjønn · Oppdatert 25. feb. 2026 · NCT07433673

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, New York
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

RekruttererFase 1/2
  • NYU Langone Health, New York
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT06682793

Endetarmskreft-studier i andre byer

Andre studier i New York City

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.